The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Verap 120mg Prolonged Release Tablets

Rowex LtdPA0711/016/004

Main Information

Trade NameVerap 120mg Prolonged Release Tablets
Active SubstancesVerapamil hydrochloride
Dosage FormProlonged-release tablet
Licence HolderRowex Ltd
Licence NumberPA0711/016/004

Group Information

ATC CodeC08DA Phenylalkylamine derivatives
C08DA01 verapamil


License statusAuthorised
Licence Issued05/10/2001
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back